Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews

Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews

Abstract Background Aliskiren is a newly developed drug. Its role in lowering BP has been recognized. However, the role of aliskiren in treating heart and renal diseases are still controversial. Objective To evaluate the existing evidence about clinical efficacy, safety and tolerability of aliskiren...

Full description

Bibliographic Details
Main Authors: Qiyuan Zhao, Jiantong Shen, Jingya Lu, Qi Jiang, Yuanyuan Wang
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Aliskiren
Monotherapy
Clinical effectiveness
Safety
Online Access:http://link.springer.com/article/10.1186/s12872-020-01442-z

Internet

http://link.springer.com/article/10.1186/s12872-020-01442-z

Similar Items